ATE308323T1 - Diaminothiazole und ihre anwendung als cdk4 inhibitoren - Google Patents
Diaminothiazole und ihre anwendung als cdk4 inhibitorenInfo
- Publication number
- ATE308323T1 ATE308323T1 AT03752731T AT03752731T ATE308323T1 AT E308323 T1 ATE308323 T1 AT E308323T1 AT 03752731 T AT03752731 T AT 03752731T AT 03752731 T AT03752731 T AT 03752731T AT E308323 T1 ATE308323 T1 AT E308323T1
- Authority
- AT
- Austria
- Prior art keywords
- diaminothiazoles
- cdk4 inhibitors
- cdk4
- inhibitors
- Prior art date
Links
- 102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 title 1
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38151302P | 2002-05-17 | 2002-05-17 | |
| PCT/EP2003/004939 WO2003097048A1 (en) | 2002-05-17 | 2003-05-12 | Diaminothiazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE308323T1 true ATE308323T1 (de) | 2005-11-15 |
Family
ID=29550137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03752731T ATE308323T1 (de) | 2002-05-17 | 2003-05-12 | Diaminothiazole und ihre anwendung als cdk4 inhibitoren |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6818663B2 (enExample) |
| EP (1) | EP1507530B1 (enExample) |
| JP (1) | JP4308133B2 (enExample) |
| KR (1) | KR100619515B1 (enExample) |
| CN (1) | CN100400041C (enExample) |
| AR (1) | AR040078A1 (enExample) |
| AT (1) | ATE308323T1 (enExample) |
| AU (1) | AU2003232754B2 (enExample) |
| BR (1) | BR0310081A (enExample) |
| CA (1) | CA2485367A1 (enExample) |
| DE (1) | DE60302152T2 (enExample) |
| ES (1) | ES2251697T3 (enExample) |
| MX (1) | MXPA04011372A (enExample) |
| PL (1) | PL374581A1 (enExample) |
| RU (1) | RU2311414C2 (enExample) |
| WO (1) | WO2003097048A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004308079A1 (en) * | 2003-12-24 | 2005-07-14 | Bayer Cropscience Ag | Plant growth regulation |
| US7211576B2 (en) * | 2004-04-20 | 2007-05-01 | Hoffmann-La Roche Inc. | Diaminothiazoles |
| US7405220B2 (en) | 2004-06-09 | 2008-07-29 | Hoffmann-La Roche Inc. | Pyrazolopyrimidines |
| US7705009B2 (en) * | 2005-11-22 | 2010-04-27 | Hoffman-La Roche Inc. | 4-aminopyrimidine-5-thione derivatives |
| WO2008054702A1 (en) | 2006-10-31 | 2008-05-08 | Schering Corporation | Anilinopiperazine derivatives and methods of use thereof |
| AU2007314305B2 (en) | 2006-10-31 | 2013-01-24 | Merck Sharp & Dohme Corp. | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| WO2010019488A1 (en) * | 2008-08-12 | 2010-02-18 | Air Products And Chemicals, Inc. | Polymeric compositions comprising per(phenylethynyl) arene derivatives |
| RU2609018C2 (ru) * | 2010-08-24 | 2017-01-30 | Джи Ти Икс, ИНК. | Соединения для лечения рака |
| US9006353B2 (en) | 2011-11-18 | 2015-04-14 | Delsper LP | Crosslinking compounds for high glass transition temperature polymers |
| AU2014253932B2 (en) | 2013-04-16 | 2020-04-30 | Memorial Sloan-Kettering Cancer Center | Companion diagnostic for CDK4 inhibitors |
| WO2015051525A1 (en) * | 2013-10-11 | 2015-04-16 | Rhodia Operations | Synthesis of acetal/ketal |
| US11921116B2 (en) | 2016-03-09 | 2024-03-05 | Memorial Sloan Kettering Cancer Center | Enigma and CDH18 as companion diagnostics for CDK4 inhibitors |
| WO2017158147A1 (en) | 2016-03-18 | 2017-09-21 | Savira Pharmaceuticals Gmbh | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| WO2018089902A1 (en) * | 2016-11-13 | 2018-05-17 | Apogee Biotechnology Corporation | Diaminothiazole compounds, compositions and methods of use |
| CN110950848B (zh) * | 2018-09-27 | 2024-03-26 | 徐诺药业 | 新型氨基吡唑类衍生物的合成与应用 |
| BR112021021663A2 (pt) | 2019-04-30 | 2022-05-17 | Inst De Medicina Molecular Joao Lobo Antunes | Inibidores da via rank em combinação com inibidores de cdk |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2714059B1 (fr) * | 1993-12-21 | 1996-03-08 | Sanofi Elf | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| EE200000289A (et) * | 1997-10-27 | 2001-06-15 | Agouron Pharmaceuticals, Inc. | Asendatud 4-amino-tiasool-2-üüli ühendid kui tsükliinisõltuvusega kinaaside inhibiitorid |
| UA71971C2 (en) * | 1999-06-04 | 2005-01-17 | Agoron Pharmaceuticals Inc | Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases |
| CA2411928A1 (en) * | 2000-08-09 | 2002-02-14 | Agouron Pharmaceuticals, Inc. | Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclindependent kinases |
| US6756374B2 (en) | 2001-01-22 | 2004-06-29 | Hoffmann-La Roche Inc. | Diaminothiazoles having antiproliferative activity |
-
2003
- 2003-05-05 US US10/429,551 patent/US6818663B2/en not_active Expired - Fee Related
- 2003-05-12 CA CA002485367A patent/CA2485367A1/en not_active Abandoned
- 2003-05-12 JP JP2004505047A patent/JP4308133B2/ja not_active Expired - Fee Related
- 2003-05-12 AT AT03752731T patent/ATE308323T1/de not_active IP Right Cessation
- 2003-05-12 RU RU2004137110/04A patent/RU2311414C2/ru active
- 2003-05-12 MX MXPA04011372A patent/MXPA04011372A/es active IP Right Grant
- 2003-05-12 PL PL03374581A patent/PL374581A1/xx not_active Application Discontinuation
- 2003-05-12 CN CNB038111314A patent/CN100400041C/zh not_active Expired - Fee Related
- 2003-05-12 AU AU2003232754A patent/AU2003232754B2/en not_active Ceased
- 2003-05-12 ES ES03752731T patent/ES2251697T3/es not_active Expired - Lifetime
- 2003-05-12 BR BR0310081-2A patent/BR0310081A/pt not_active IP Right Cessation
- 2003-05-12 KR KR1020047018605A patent/KR100619515B1/ko not_active Expired - Fee Related
- 2003-05-12 DE DE60302152T patent/DE60302152T2/de not_active Expired - Fee Related
- 2003-05-12 WO PCT/EP2003/004939 patent/WO2003097048A1/en not_active Ceased
- 2003-05-12 EP EP03752731A patent/EP1507530B1/en not_active Expired - Lifetime
- 2003-05-15 AR ARP030101692A patent/AR040078A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2251697T3 (es) | 2006-05-01 |
| DE60302152D1 (de) | 2005-12-08 |
| CA2485367A1 (en) | 2003-11-27 |
| RU2311414C2 (ru) | 2007-11-27 |
| KR20050006261A (ko) | 2005-01-15 |
| US6818663B2 (en) | 2004-11-16 |
| JP2005530783A (ja) | 2005-10-13 |
| AR040078A1 (es) | 2005-03-16 |
| JP4308133B2 (ja) | 2009-08-05 |
| AU2003232754B2 (en) | 2009-03-12 |
| WO2003097048A1 (en) | 2003-11-27 |
| RU2004137110A (ru) | 2005-08-20 |
| EP1507530A1 (en) | 2005-02-23 |
| EP1507530B1 (en) | 2005-11-02 |
| BR0310081A (pt) | 2005-02-15 |
| DE60302152T2 (de) | 2006-07-13 |
| CN100400041C (zh) | 2008-07-09 |
| US20040006058A1 (en) | 2004-01-08 |
| KR100619515B1 (ko) | 2006-09-08 |
| PL374581A1 (en) | 2005-10-31 |
| AU2003232754A1 (en) | 2003-12-02 |
| CN1652780A (zh) | 2005-08-10 |
| MXPA04011372A (es) | 2005-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60208661D1 (de) | Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren | |
| ATE521598T1 (de) | 5-phenylthiazol-derivate und ihre verwendung als pi3 kinase inhibitoren | |
| DE60314600D1 (de) | O-cyclopropyl-carboxanilide und ihre verwendung als fungizide | |
| DE60308387D1 (de) | Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren | |
| DE602005016890D1 (de) | Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren | |
| IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
| ATE435859T1 (de) | Gyraseinhibitoren und deren verwendungen | |
| ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
| DE60309874D1 (de) | Malonsäuerenitril-verbindungen und ihre verwendung als pestizide | |
| ATE299881T1 (de) | 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren | |
| ATE269701T1 (de) | Gyrase-inhibitoren und ihre verwendung | |
| DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
| DE60219068D1 (de) | Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren | |
| IS7700A (is) | Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar | |
| DE602004028934D1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
| DE50313157D1 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| ATE308323T1 (de) | Diaminothiazole und ihre anwendung als cdk4 inhibitoren | |
| ATE329906T1 (de) | Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren | |
| ATE399768T1 (de) | Indazolderivate und ihre verwendung als crf antagonisten | |
| ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
| DE502005007106D1 (de) | Substituierte phenylaminothiazole und ihre verwendung | |
| ATE382040T1 (de) | Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren | |
| DE60328978D1 (de) | Isochinolinderivate als mao-b inhibitoren | |
| ATE499096T1 (de) | Kombination von serotonin-wiederaufnahme-hemmern und agomelatin | |
| DE602004004794D1 (de) | Nicotinamid-derivate verwendbar als pde4 inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1507530 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |